[The calcipotriol-betamethasone dipropionate association]
- PMID: 16402537
[The calcipotriol-betamethasone dipropionate association]
Abstract
The topical treatment of psoriasis benefits from the alternate use of dermocorticosteroids and vitamin D3 analogues. A new galenic formulation allows to combine them in a single application. Dovobet (LEO Pharma) ointment is the association of calcipotriol 50 microg/g with betamethasone dipoprionate 0.5 mg/g. This formulation boosts the therapeutic activity of calcipotriol. It also decreases the irritative inflammatory reaction due to calcipotriol without increasing the atrophogenic risk of the dermocorticoid.
Similar articles
-
Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.Br J Dermatol. 2004 Jun;150(6):1167-73. doi: 10.1111/j.1365-2133.2004.05986.x. Br J Dermatol. 2004. PMID: 15214905 Clinical Trial.
-
Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.Skin Therapy Lett. 2002 Jun;7(6):1-3. Skin Therapy Lett. 2002. PMID: 12223976 Review.
-
The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.Br J Dermatol. 2004 Sep;151(3):663-8. doi: 10.1111/j.1365-2133.2004.06134.x. Br J Dermatol. 2004. PMID: 15377355 Clinical Trial.
-
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.Drugs. 2011 Apr 16;71(6):709-30. doi: 10.2165/11207300-000000000-00000. Drugs. 2011. PMID: 21504248 Review.
-
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.Am J Clin Dermatol. 2004;5(6):463-78. doi: 10.2165/00128071-200405060-00012. Am J Clin Dermatol. 2004. PMID: 15663344
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical